All Type of News
Industries with different opinions about small packaging
Ove the issue of supplying medicines in small packaging, a clear gap between pharmaceutical companies and pharmacists was once again confirmed.
When it comes to this issues, the Ministry of Food and Drug Safety asked...
Government makes stricter admonitive measures for false reports about adverse drug reactions
In order to raise credibility of clinical trials, the government will make administrative measures stricter as imposing disciplinary fines for falsely reporting adverse drug reactions.
The Ministry of Food and Drug S...
UAE’s Emir of Ras Al Khaimah visits Kolong Life Science and Kolo TissueGene
Kolon Life Science/Kolon TissueGene(CEO Woo-Seok Lee) announced on the 3rd that Sheikh Saud bin Saqr Al-Qasimi, the current emir of Ras Al Khaimah, and other 13 national guests visited ‘Kolon One&Only Tower’ located i...
Celltrion Healthcare starts to sell ‘Herzuma’ in Europe
Celltrion Healthcare announced on the 3rd that ‘Herzuma(generic name: trastuzumab),’ an antibody biosimilar for the treatment of breast cancer and stomach cancer, was first launched in the U.K. It is an early launch w...
MFDS to create ‘Guideline for Prompt Drug Evaluation’ this June
The Ministry of Food and Drug Safety(MFDS) will establish a guideline to clarify terms and subject for the rapid prompt assessment system before enforcement at the National Assembly.
Drug Evaluation Coordination Mana...
SK Chemicals is planning to found a new company for its vaccine business
SK Chemical will split up the vaccine business.
SK Chemical announced to decide to demerge the VAX business unit and create a new company at the board meeting on the 2nd. The new company’s name was reportedly ‘SK Bi...
MFDS distributes safety letter about epilepsy and bipolar treatment ‘lamotrigine’
On the 2nd, the Ministry of Food and Drug Safety(Minister Young-Jin Ryu, MFDS) announced to distribute a safety letter which has health care providers stop prescribing and dispensing once a patient is suspicious of ha...
Will Cyramza with health insurance benefits broaden options for stomach cancer patients?
Will ‘Cyramza(generic name: ramucirumab),’ a secondary treatment for stomach cancer, break the wall of health insurance benefits and become a practical treatment option for stomach cancer patients?
Lilly Korea, on th...
Increase in OTC drug approval
The number of OTC drug approvals has increased since this year. The percentage of approvals for OTC drugs is reaching 27% by this April.
According to the Ministry of Food and Drug Safety(MFDS) Online Library, there w...
Pharmas active in developing antihypertensive combination drugs
Ever since the incrementally modified drug system was adopted in 2009, total 16 products were approved as a combination therapy for hypertension.
Moreover, antihypertensives are reportedly moving towards a trend with...
